Sunmedical logo
Medium-term outcomes after robotic-assisted lateral suspension with mesh for advanced multi-compartmental prolapse
2019 - Eleonora Russo, Andrea Giannini, Magdalena Montt Guevara, Paolo Mannella, Giulia Misasi, Maria Falcone, Tommaso Simoncini

Medium-term outcomes after robotic-assisted lateral suspension with mesh for advanced multi-compartmental prolapse

This study completed a prospective case series of 115 RALS to treat apical and anterior prolapse stage III or IV, with no or minimal (stage I) posterior defect. Mean follow-up was 28 ± 4 months. Primary outcomes were objective and subjective cure; secondary outcomes were reoperation rate for recurrence, erosion rate and complications. 

Results There was a significant improvement in POP-Q score in all treated compartments with an objective cure rate of 88.7% for the anterior and 93.1% for the apical compartment (p < 0.0001)

Self-retaining support implant: an anchorless system for the treatment of pelvic organ prolapse-2-year follow-up
2019 - Levy, Padoa, Fekete, Bartfai, Pajor, Cervigni

Self-retaining support implant: an anchorless system for the treatment of pelvic organ prolapse-2-year follow-up

Introduction and hypothesis The search for an improved vag- inal mesh prompted the development of a new anchorless implant. The objective was to report on outcome after 2 years of a technique using a self-retaining support (SRS) implant.

Int Urogynecol J

Mesh versus acellular dermal matrix in immediate implantbased breast reconstructione A prospective randomized trial
2016 - D. Gschwantler-Kaulich, P. Schrenk, V. Bjelic-Radisic, K. Unterrieder, C. Leser, A. Fink-Retter, M. Salama, C. Singer

Mesh versus acellular dermal matrix in immediate implantbased breast reconstructione A prospective randomized trial

This prospective, randomized, controlled, multicenter pilot study was performed at four Austrian breast cancer centers. Fifty patients with oncologic or prophylactic indication for mastectomy and IBBR were randomized to immediate IBBR with either an ADM(Protexa) or a titanized mesh (TiLOOPBra).

Da evidenziare sia il 30% di perdita di impianto nel gruppo di Protexa(contro il 7 % di tiloop),sia il miglior outcome estetico e grado di soddisfazione del gruppo Tiloop BRA.

Subcutaneous Direct-to-Implant Breast Reconstruction: Surgical, Functional, and Aesthetic Results after Long-Term Follow-Up
2016 - Donato Casella ,Lorenzo Orzalesi, Marco Bernini, Claudio Calabrese, Jenny Roselli, Lorenzo Cecconi, Caterina Santi, Ulpjana Gjondedaj, Jacopo Nori, Alfonso Fausto

Subcutaneous Direct-to-Implant Breast Reconstruction: Surgical, Functional, and Aesthetic Results after Long-Term Follow-Up

Aim of this study is to analyze the long-term results, both objective and subjective, of a previous nonrandomized trial comparing pre- pectoral (subcutaneous) and retropectoral breast reconstructions using Titanized Mesh

A multicenter collaboration to asses the safety of laparoscopic ventral rectopexy
2015 - Evans C, Stevenson AR, Sileri P, Mercer-Jones MA, Dixon AR, Cunningham C, Jones OM, Lindsey I.

A multicenter collaboration to asses the safety of laparoscopic ventral rectopexy

This study aimed to determine the risk of mesh and nonmesh morbidity after laparoscopic ventral rectopexy and to compare the safety of synthetic meshes with biological grafts.

Dis Colon Rectum. 2015 Aug;58(8):799-807

Abstract London Breast Meeting 2014: Non-absorbable synthetic mesh tiloop
2014 - Donato Casella, Breast Unit AOU Careggi-Firenze Vittorio Zanini, Fondazione Maugeri Pavia

TiLoop® Bra mesh used for immediate breast reconstruction

Di seguito la lettura tenuta dal Dott. Nava durante il "Lonodn Breast Meeting 2014"sull'utilizzo della rete Tiloop Bra.

1 2 3 4